Clinical Trials Directory

Trials / Unknown

UnknownNCT03295903

Cannabinoid Supplementation on Vascular and Cognitive Function

The Effects of Cannabinoids on Vascular and Cognitive Function in Young and Old Healthy Adults.

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Cannabidiol (CBD) is a bioactive cannabinoid compound in marijuana (cannabis sativa), but unlike Δ9 tetrahydrocannabinol (THC), lacks the psychoactivity effect of THC. Available evidence suggests that there are marked therapeutic CBD effects for diverse disease processes including inflammation, cancers, psychosis, and epileptic seizures. The purpose of this study, in both younger and older healthy humans, is to improve our understanding of how CBD might control and regulate blood vessel health as well as cognitive and exercise performance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCannabidiol supplementSubjects will be administered in a double-blinded, randomized and cross-over design

Timeline

Start date
2018-01-01
Primary completion
2021-09-30
Completion
2021-10-01
First posted
2017-09-28
Last updated
2019-10-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03295903. Inclusion in this directory is not an endorsement.

Cannabinoid Supplementation on Vascular and Cognitive Function (NCT03295903) · Clinical Trials Directory